SMPD1 and depressive symptom measurement: In contrast, increasing ceramide levels such as by overexpressing ASM, blocking ceramide degradation, or directly injecting C16 ceramide into the hippocampus results in reduced neurogenesis and depression-like behavior, even in the absence of stress.